Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Leases: 2019-2021

Historic Operating Leases for Cogent Biosciences (COGT) over the last 3 years, with Sep 2021 value amounting to $1.4 million.

  • Cogent Biosciences' Operating Leases fell 61.04% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year decrease of 61.04%. This contributed to the annual value of $3.2 million for FY2020, which is 28.51% down from last year.
  • Latest data reveals that Cogent Biosciences reported Operating Leases of $1.4 million as of Q3 2021, which was down 29.20% from $2.0 million recorded in Q2 2021.
  • Cogent Biosciences' Operating Leases' 5-year high stood at $5.6 million during Q1 2019, with a 5-year trough of $1.4 million in Q3 2021.
  • Moreover, its 3-year median value for Operating Leases was $3.7 million (2020), whereas its average is $3.7 million.
  • Data for Cogent Biosciences' Operating Leases shows a maximum YoY plummeted of 61.04% (in 2021) over the last 5 years.
  • Over the past 3 years, Cogent Biosciences' Operating Leases (Quarterly) stood at $4.4 million in 2019, then fell by 28.51% to $3.2 million in 2020, then tumbled by 61.04% to $1.4 million in 2021.
  • Its Operating Leases stands at $1.4 million for Q3 2021, versus $2.0 million for Q2 2021 and $2.6 million for Q1 2021.